PubRank

American journal of nuclear medicine and molecular imaging (Am J Nucl Med Mol Imaging)

Journal PubWeight™ 178.09‹?›

Top papers

Rank Title Year PubWeight™‹?›
151 Assessment of an elastin binding molecule for PET imaging of atherosclerotic plaques. 2013 0.77
152 Feasibility of simultaneous PET/MR in diet-induced atherosclerotic minipig: a pilot study for translational imaging. 2014 0.77
153 Synthesis and pre-clinical evaluation of an (18)F-labeled single-chain antibody fragment for PET imaging of epithelial ovarian cancer. 2016 0.77
154 Myocardial blood flow measurement with a conventional dual-head SPECT/CT with spatiotemporal iterative reconstructions - a clinical feasibility study. 2013 0.76
155 Performance characteristics and relationship of PSA value/kinetics on carbon-11 acetate PET/CT imaging in biochemical relapse of prostate cancer. 2017 0.76
156 Multi-radionuclide digital autoradiography of the intra-aortic atherosclerotic plaques using a monoclonal antibody targeting oxidized low-density lipoprotein. 2014 0.76
157 Quantitative myocardial blood flow with Rubidium-82 PET: a clinical perspective. 2015 0.76
158 Feasibility of (18)F-Fluorodeoxyglucose radiotracer dose reduction in simultaneous carotid PET/MR imaging. 2015 0.76
159 Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma. 2015 0.76
160 Synthesis and evaluation of (68)Ga-labeled DOTA-2-deoxy-D-glucosamine as a potential radiotracer in μPET imaging. 2012 0.76
161 Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma. 2014 0.76
162 Multiplexing SERS nanotags for the imaging of differentiated mouse embryonic stem cells (mESC) and detection of teratoma in vivo. 2014 0.76
163 (18)F-Deoxyglucose (FDG) kinetics evaluated by a non-compartment model based on a linear regression function using a computer based simulation: correlation with the parameters of the two-tissue compartment model. 2012 0.76
164 Design, synthesis and in vitro characterization of fluorescent and paramagnetic CXCR4-targeted imaging agents. 2013 0.76
165 Bioluminescence imaging of therapy response does not correlate with FDG-PET response in a mouse model of Burkitt lymphoma. 2012 0.76
166 (68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2. 2016 0.76
167 Prediction of positron emission tomography/computed tomography (PET/CT) positivity in patients with high-risk primary melanoma. 2016 0.75
168 Molecular MRI of atherosclerotic plaque progression in an ApoE(-/-) mouse model with a CLT1 peptide targeted macrocyclic Gd(III) chelate. 2013 0.75
169 Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer. 2014 0.75
170 Synthesis and evaluation of 2-(18)F-fluoro-5-iodo-3-[2-(S)-3,4-dehydropyrrolinylmethoxy]pyridine ((18)F-Niofene) as a potential imaging agent for nicotinic α4β2 receptors. 2014 0.75
171 SUV measurement of normal vertebrae using SPECT/CT with Tc-99m methylene diphosphonate. 2016 0.75
172 Genetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approach. 2016 0.75
173 Automated synthesis and dosimetry of 6-deoxy-6-[(18)F]fluoro-D-fructose (6-[(18)F]FDF): a radiotracer for imaging of GLUT5 in breast cancer. 2014 0.75
174 Long-term quality assurance of [(18)F]-fluorodeoxyglucose (FDG) manufacturing. 2016 0.75
175 May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreotate. 2013 0.75
176 Validation of true low-dose (18)F-FDG PET of the brain. 2016 0.75
177 Sexually immature male ERE-Luc reporter mice to assess low dose estrogen-like effects of CdCl2 versus dietary Cd. 2014 0.75
178 Alzheimer's disease imaging with a novel Tau targeted near infrared ratiometric probe. 2013 0.75
179 Quantitative (99m)Tc DTPA renal transplant scintigraphic parameters: assessment of interobserver agreement and correlation with graft pathologies. 2014 0.75
180 PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5). 2011 0.75
181 What role for radiobiphosphonates bone scintigraphy in the monitoring of an unusual bone giant cell tumor: a case report and literature review. 2016 0.75
182 Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis. 2016 0.75
183 Absorbed radiation dosimetry of the D3-specific PET radioligand [(18)F]FluorTriopride estimated using rodent and nonhuman primate. 2016 0.75
184 Feasibility of carotid artery PET/MRI in psoriasis patients. 2016 0.75
185 [(11)C]PiB PET in Gerstmann-Sträussler-Scheinker disease. 2016 0.75
186 Impact of expectation-maximization reconstruction iterations on the diagnosis of temporal lobe epilepsy with PET. 2012 0.75
187 In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probe. 2015 0.75
188 Imaging radiation response in tumor and normal tissue. 2015 0.75
189 (18)F-FDG PET/CT and pain in metastatic bone cancer. 2015 0.75
190 Dosage optimization in positron emission tomography: state-of-the-art methods and future prospects. 2015 0.75
191 Application of (18)F-FDG PET and diffusion weighted imaging (DWI) in multiple myeloma: comparison of functional imaging modalities. 2015 0.75
192 The sensitivity and specificity of F-DOPA PET in a movement disorder clinic. 2016 0.75
193 Bioluminescence imaging of estrogen receptor activity during breast cancer progression. 2016 0.75
194 A comparison of PET imaging agents for the assessment of therapy efficacy in a rodent model of glioma. 2013 0.75
195 (18)F-FDG PET imaging in detection of radiation-induced vascular disease in lymphoma survivors. 2015 0.75
196 OKN-007 decreases VEGFR-2 levels in a preclinical GL261 mouse glioma model. 2015 0.75
197 Measurement of hypoxia-related parameters in three sublines of a rat prostate carcinoma using dynamic (18)F-FMISO-Pet-Ct and quantitative histology. 2015 0.75
198 The benefit of personalized hybrid SPECT/CT pulmonary imaging. 2016 0.75
199 PET imaging reveals sex differences in kappa opioid receptor availability in humans, in vivo. 2016 0.75
200 Diagnosis of abnormal biliary copper excretion by positron emission tomography with targeting of (64)Copper-asialofetuin complex in LEC rat model of Wilson's disease. 2014 0.75
Next 50